Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …

In the cardio-oncology population, drug interactions are of particular importance given the
complex pharmacological profile, narrow therapeutic index, and inherent risk of therapies …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …

The incidence of arrhythmia after myocardial infarction has declined since the introduction of
reperfusion techniques. Nevertheless, ischemic arrhythmias are often associated with …

Abstract Purpose of Review Multiple guidelines and recommendations have been written to
address the perioperative management of antiplatelet and anticoagulant drugs. In this …

The lubrication modification of biomedical devices significantly enhances the functionality of
implanted interventional medical devices, thereby providing additional benefits for patients …

Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation
and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are …

• Proton pump inhibitors (PPIs) are effective and widely used, but often for longer than
needed, adding to medication burden and resource waste• Discuss with patients reducing or …

Importance Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for
2 main purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for …